GE Stock Analysis: GE Aerospace | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 331.792m USD | 12M Return: 3.8% | US3696043013 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.31B
EPS Trend: 98.6%
Qual. Beats: 7
Rev. Trend: -26.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
GE Aerospace (NYSE: GE) is the aerospace business of the former General Electric Company, focused on designing and producing commercial and defense aircraft engines, integrated engine components, electric power, and aircraft systems. The company operates through two reporting segments: Commercial Engines & Services, which covers jet engines and MRO for commercial airframes, business aviation, and aeroderivative applications, and Defense & Propulsion Technologies, which serves governments, militaries, and commercial airframers with engines, avionics, and power systems. Both segments generate revenue from a mix of original equipment sales and higher-margin aftermarket parts and services, a business model common across large engine OEMs.
The Defense & Propulsion Technologies segment also produces aircraft components and systems, including small turboprops, mechanical transmissions, turbines, combustors and controls, additive-manufactured parts, propeller systems, ignition systems, and engine accessories, marketed under the Avio Aero, Unison, Dowty Propellers, and Colibrium Additive brands for fixed-wing and rotorcraft applications. GE Aerospace operates globally across the United States, Europe, Asia, the Americas, the Middle East, and Africa, and competes in the GICS Aerospace & Defense sub-industry alongside other major engine manufacturers and Tier-1 suppliers.
General Electric Company was incorporated in 1892 and is headquartered in Evendale, Ohio. GE trades as a mega-cap stock in the Industrials sector following the 2024 separation of its power (GE Vernova) and healthcare (GE HealthCare) businesses, which left GE Aerospace as a standalone, pure-play aerospace and defense company.
- Aftermarket services revenue drives margin expansion
- Defense backlog grows with rising military spending
- LEAP engine deliveries ramp with narrowbody recovery
| Net Income: 8.97b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.19 > 1.0 |
| NWC/Revenue: -1.45% < 20% (prev 3.21%; Δ -4.65% < -1%) |
| CFO/TA 0.08 > 3% & CFO 9.80b > Net Income 8.97b |
| Net Debt (11.8b) to EBITDA (11.8b): 1.00 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.05b) vs 12m ago -1.72% < -2% |
| Gross Margin: 35.44% > 18% (prev 37.92%; Δ -2.49% > 0.5%) |
| Asset Turnover: 40.07% > 50% (prev 33.22%; Δ 6.85% > 0%) |
| Interest Coverage Ratio: 11.45 > 6 (EBIT TTM 10.5b / Interest Expense TTM 920.0m) |
| A: -0.01 (Total Current Assets 39.7b - Total Current Liabilities 40.4b) / Total Assets 128b |
| B: 0.71 (Retained Earnings 91.0b / Total Assets 128b) |
| C: 0.08 (EBIT TTM 10.5b / Avg Total Assets 126b) |
| D: 0.16 (Book Value of Equity 17.6b / Total Liabilities 110b) |
| Altman-Z'' = 3.01 = A |
| DSRI: 0.75 (Receivables 12.4b/13.6b, Revenue 50.7b/41.6b) |
| GMI: 1.07 (GM 37.92% / 35.44%) |
| AQI: 0.98 (AQ_t 0.63 / AQ_t-1 0.64) |
| SGI: 1.22 (Revenue 50.7b / 41.6b) |
| TATA: -0.01 (NI 8.97b - CFO 9.80b) / TA 128b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of October 04, 2026, the stock is trading at USD 309.56 with a total of 4,148,627 shares traded. Over the past week, the price has changed by -5.36%, over one month by -6.05%, over three months by -17.90% and over the past year by +3.77%.
Current recommended Stop Loss: 288.30 (which is 6.9% or 2.5 ATR below the current price).
GE Aerospace has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy GE.
- StrongBuy: 13
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 400.1 | 29.2% |
P/E Trailing = 37.7544
P/E Forward = 35.3357
P/S = 6.5521
P/B = 18.7761
P/EG = 4.0588
Revenue TTM = 50.7b USD
EBIT TTM = 10.5b USD
EBITDA TTM = 11.8b USD
Long Term Debt = 17.2b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 21.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.97b
Net Debt = 11.8b USD (calculated: Debt 21.1b - CCE 9.35b)
Enterprise Value = 344b USD (332b + Debt 21.1b - CCE 9.35b)
Interest Coverage Ratio = 11.45 (Ebit TTM 10.5b / Interest Expense TTM 920.0m)
EV/FCF = 40.92x (Enterprise Value 344b / FCF TTM 8.40b)
FCF Yield = 2.44% (FCF TTM 8.40b / Enterprise Value 344b)
FCF Margin = 16.57% (FCF TTM 8.40b / Revenue TTM 50.7b)
Net Margin = 17.70% (Net Income TTM 8.97b / Revenue TTM 50.7b)
Gross Margin = 35.44% ((Revenue TTM 50.7b - Cost of Revenue TTM 32.7b) / Revenue TTM)
Gross Margin QoQ = 35.03% (prev 36.07%)
Tobins Q-Ratio = 2.69 (Enterprise Value 344b / Total Assets 128b)
Interest Expense / Debt = 4.35% (Interest Expense 920.0m / Debt 21.1b)
Taxrate = 13.44% (1.39b / 10.4b)
NOPAT = 9.12b (EBIT 10.5b * (1 - 13.44%))
Current Ratio = 0.98 (Total Current Assets 39.7b / Total Current Liabilities 40.4b)
Debt / Equity = 1.20 (Debt 21.1b / totalStockholderEquity, last quarter 17.6b)
Debt / EBITDA = 1.00 (Net Debt 11.8b / EBITDA 11.8b)
Debt / FCF = 1.40 (Net Debt 11.8b / FCF TTM 8.40b)
Total Stockholder Equity = 18.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.09% (Net Income 8.97b / Total Assets 128b)
RoE = 49.03% (Net Income TTM 8.97b / Total Stockholder Equity 18.3b)
RoCE = 29.71% (EBIT 10.5b / Capital Employed (Equity 18.3b + L.T.Debt 17.2b))
RoIC = 10.52% (NOPAT 9.12b / Invested Capital 86.7b)
WACC = 9.61% (E(332b)/V(353b) * Re(9.98%) + D(21.1b)/V(353b) * Rd(4.35%) * (1-Tc(0.13)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.93 | Cagr: -2.22%
[DCF] Terminal Value 74.01% ; FCFF base≈7.23b ; Y1≈8.29b ; Y5≈12.2b
[DCF] Fair Price = 133.5 (EV 150b - Net Debt 11.8b = Equity 139b / Shares 1.04b; r=9.61% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.63 | EPS CAGR: 42.25% | SUE: 1.95 | # QB: 7
Revenue Correlation: -26.18 | Revenue CAGR: -2.98% | SUE: 1.07 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.99 | Chg30d=+0.04% | Revisions=+42% | Analysts=17
EPS current Year (2026-12-31): EPS=7.91 | Chg30d=+0.02% | Revisions=+88% | GrowthEPS=+24.2% | GrowthRev=+18.9%
EPS next Year (2027-12-31): EPS=9.69 | Chg30d=-0.29% | Revisions=+75% | GrowthEPS=+13.5% | GrowthRev=+10.9%
[Analyst] Revisions Ratio: +78% (up=42, down=4)